80 Hong Kong Pharmaceuticals & Biotech Stocks - Strong Balance Sheet Stocks - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1875 TOT BIOPHARM International	HK$1.94	-3.0%	-27.9%	HK$1.5b	HK$3.80	PS1.8x	n/a	n/a
6998 Genor Biopharma Holdings	HK$1.46	5.0%	-19.3%	HK$743.0m	n/a	PB0.6x	n/a	n/a
1889 Sanai Health Industry Group	HK$0.027	0%	-65.8%	HK$103.2m	n/a	PE5.1x	n/a	0%
1681 Consun Pharmaceutical Group	HK$6.84	-4.5%	37.6%	HK$5.5b	HK$7.87	PE6.5x	E14.4%	8.7%
570 China Traditional Chinese Medicine Holdings	HK$4.26	-0.9%	7.6%	HK$21.5b	HK$4.82	PE15.5x	E12.3%	0%
1530 3SBio	HK$6.31	-4.2%	-21.5%	HK$15.0b	HK$7.45	PE9x	E12.7%	3.9%
2161 JBM (Healthcare)	HK$0.96	-5.9%	-9.4%	HK$794.9m	n/a	PE8.1x	n/a	7.2%
2137 Brii Biosciences	HK$1.37	9.6%	-65.6%	HK$999.8m	HK$4.67	PS16.5x	E20.2%	n/a
3613 Beijing Tong Ren Tang Chinese Medicine	HK$10.26	-1.9%	-30.7%	HK$8.6b	HK$13.93	PE15.9x	E15.2%	3.2%
2126 JW (Cayman) Therapeutics	HK$2.35	-8.6%	-24.9%	HK$948.8m	HK$2.72	PS5.1x	E28.3%	n/a
719 Shandong Xinhua Pharmaceutical	HK$5.73	-3.0%	-12.0%	HK$9.7b	n/a	PE7.4x	n/a	4.7%
1643 Modern Chinese Medicine Group	HK$0.40	9.7%	-19.4%	HK$237.0m	n/a	PE4.5x	n/a	0%
1061 Essex Bio-Technology	HK$2.54	1.2%	-27.8%	HK$1.4b	n/a	PE5.2x	n/a	3.5%
1666 Tong Ren Tang Technologies	HK$5.77	-0.3%	-21.0%	HK$7.4b	HK$6.55	PE11.6x	E4.5%	3.4%
1312 Kontafarma China Holdings	HK$0.038	5.6%	-13.6%	HK$212.4m	n/a	PB0.2x	n/a	0%
6996 Antengene	HK$1.02	5.2%	-51.2%	HK$688.4m	HK$1.81	PS9.5x	E19.6%	n/a
1952 Everest Medicines	HK$23.75	-7.2%	91.8%	HK$7.6b	HK$28.20	PS56x	E76.3%	n/a
6600 SciClone Pharmaceuticals (Holdings)	HK$18.32	0.7%	70.6%	HK$11.1b	HK$17.86	PE9.2x	E4.7%	0%
1672 Ascletis Pharma	HK$1.33	-4.3%	-41.9%	HK$1.3b	HK$2.98	PS22.1x	E-9.3%	n/a
9966 Alphamab Oncology	HK$4.90	-6.1%	-44.4%	HK$4.7b	HK$3.93	PS20x	E1.6%	n/a
8225 China Health Group	HK$0.11	-6.7%	-48.9%	HK$111.5m	n/a	PS4.8x	n/a	n/a
867 China Medical System Holdings	HK$6.78	-9.1%	-45.0%	HK$16.5b	HK$10.90	PE6.4x	E6.8%	6.2%
239 Pak Fah Yeow International	HK$2.66	13.2%	87.3%	HK$829.0m	n/a	PE7.9x	n/a	7.7%
1349 Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd	HK$2.20	-0.9%	-24.9%	HK$6.5b	n/a	PE20.7x	n/a	3.4%

Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks